Merck Sells Stake in Moderna as Vaccine Gets FDA Review

(Bloomberg) -- Merck & Co. said it sold its stake in Moderna Inc., the biotechnology company that’s in the midst of developing a Covid-19 vaccine. The shares of both companies rose.